Session 1295: Immunotherapy
Cochair(s): J Gibbs, JW Hodge
Date: Tue 12 February 2002,
Time: 14:00 - 16:00
Location: Amphithéâtre Duclaux
Oral Presentations
| Time |
Number |
Title / Authors / Affiliations |
| 14:00 |
539 |
Preclinical
efficacy of dendritic cell immunotherapy for CNS
tumors
AB Heimberger, LE Crotty, GE Archer, M Lendon, DD Bigner,
JH Sampson
Duke University Medical
Center, Durham, NC United States |
| 14:15 |
540 |
Uptake and
differential degradation of p53 mutants by dendritic
cells from necrotic Saos-p53 positive
cells.
M Ardle, R Germack, S Ali, RC Rees
Nottingham Trent
University, Nottingham, Nottinghamshire United
Kingdom |
| 14:30 |
541 |
Tumour associated
antigen ctls induced by direct intra-tumour injection of
disc-hsv specifically traffic to parental tumour
microcirculation in murine model
SA Ali
Department of Life
Sciences, Nottingham Trent University Clifton
Lane |
| 14:45 |
542 |
Association of
clinical and immunological responses to an autologous,
hapten-modified human cancer vaccine.
D Berd
Thomas Jefferson
University, Philadelphia, USA |
| 15:00 |
543 |
Human
immunoRNases as selective and non-immunogenic anticancer
agents
G D'Alessio, C De Lorenzo, D Palmer, R Piccoli
1Dipartimento
di Chimica Biologica, University of Naples Federico II,
Napoli, Italy, 2Department of Immunology,
Imperial College, London, U.K |
| 15:15 |
544 |
Immunisation with
a nonapeptide expressed in human tumors is able to reduce
tumor growth in a rat experimental
model.
S Vallebona, G Rasi, P Bernard, P Pierimarchi, FG , E
Garaci
1University
of Tor Vergata, Roma, Italy, 2Istitute of
Neurobiology and Molecolar Medicine, Italy,
3Cancer Istitute Regina Elena, Rome,
Italy |
| 15:30 |
545 |
Exploitation of
photodynamic therapy-generated immune response in cancer
immunotherapy
M Korbelik
British Columbia Cancer
Agency, Vancouver, Canada |
Poster Presentations
| Number |
Title / Authors / Affiliations |
| 546 |
Quantitative and
qualitative deficits of peripheral gd T cells in patients
with active nasopharyngeal carcinoma
BJ Zheng, SP Ng, D Chua, JST Sham, D Kwong, CK Lam, MH
Ng
1Department
of Microbiology, 2Department of Radiation
Oncology; The University of Hong Kong, Hong Kong, Peoples
Republic of China, 3Hematology Section,
Department of Pathology, Queen Mary Hospital, Hong Kong,
Peoples Republic of China |
| 547 |
A monoclonal
antibody for esophageal squamous cell carcinoma and
immunotargeting therapy.
T Tanaka, U Toh, T Fujii, S Sueyoshi, H Fujita, K
Shirouzu, H Yamana
1Multidisciplinary
treatment center, 2Department of Surgery;
Kurume University School of Medicine, Kurume, Japan
Email:totanaka@med.kurume-u.ac.jp |
| 548 |
Immunopathological
study of secretory Iga expression in helicobacter
pylori-infected gastric mucosa
KD Dimopoulou, E Kairi-Vassilatou, M Frangou, M Eglezou,
K Kontoyanni, A Kondi-Pafiti
Areteion Hospital,
Athens University Medical School-Greece, Athens, Attica
Greece |
| 549 |
Effects of
TGFbeta on B cells of vaccinated NOD mice are dependent
on costimulation via CD40: role for inhibitory
Smads?
TC Martins, AP Águas
1Institute
for Molecular and Cell Biology, Porto, Portugal Portugal,
2Abel Salazar Institute for the Biomedical
Sciences, University of Porto, Porto,
Portugal |
| 550 |
The protective
role of IgE in ovarian carcinoma.
SN Karagiannis, Q Wang, N East, F Burke, FR Balkwill, HJ
Gould
1GKT School
of Biomedical Sciences, The Randall Centre, London,
United Kingdom, 2ICRF Translational Oncology
Laboratory, St Bartholomew's and The Royal London School
of Medicine & Dentistry, London, United
Kingdom |
| 551 |
*Anti-idiotypic
antibodies induced by genetic immunization are directed
exclusively against combined V_(L)/V_(H) determinants:
implications on the mechanism of
protection
F Benevenuti, M Cesco-Gaspere, OR Burrone
1Institute
Curie, INSERM U520, Paris, France,
2International Centre for Genetic Engineering
and Biotechnology, Trieste, Italy |
| 552 |
The influence of
low dose recombinant interleukin-2 (rIL-2) therapy on
immunological system of patients previously treated with
purine analogues.
MM Malek, A Dmoszynska, A Goracy, D Jawniak, W
Legiec
Department of
Haematooncology and Bone Marrow Transplantation Center,
University Medical School in Lublin, Poland |
| 553 |
Bcl-2 antisense
oligonucleotides in the treatment neoplastic diseases in
children
A Chybicka, R Chaber, J Toporski
Department of Pediatric
Oncology and Hematology, Wroclaw Medical
University |
| 554 |
Immature and
mature dendritic cells in mammary Paget's
disease.
T Brunhuber, C Ensinger, G Mikuz, N Romani, S Saeland, S
Lebecque, P Obrist
1Department
of Pathology, 2Department of Dermatology;
University of Innsbruck Medical School, Innsbruck,
Austria, 3Schering-Plough Laboratory for
Immunological Research, Dardilly, France |
| 555 |
Immune system
alterations in lung cancer patients
G Mazzoccoli, M Grilli, S Carughi, F Puzzolante, A De
Cata, M La Viola, A Giuliani, R Tarquini, F
Perfetto
Dept Internal Medicine
Reg General Hospital Casa Sollievo Sofferenza Cappuccini
Av I-71013 S Giovanni Rotondo, Italy |
| 556 |
The predictive
value of tumour-infiltrating lymphocytes for response to
immunotherapy.
A Håkansson, B Gustafsson, L Håkansson
1Department
of Oncology, Divison of Clinical Tumour Immunology,
2Department of Pathology and Cytology;
University Hospital, Sweden |
| 557 |
Effects of oral
administration of Echinacea purpurea (American herb) and
Pfaffia paniculata (Brazilian ginseng) in combination
with iso-maltooligomers derived from corn starch on
incidence of spontaneous leukemia in AKR/J
mice
T Watanabe, T Asahi, M Watanabe, Y Watanabe, Y
Yanagimoto
1Division of
Res. & Develop. Mie Chemical Foods Company, Mie,
Japan, 2Dept. of Human Welfare, International
Buddhist University, Habikino, Osaka, Japan |
|
Site Contents
- The Journal
- CDP, a peer-refereed
bi-monthly on predictive and preventive oncology
- The Society
- The International Society for Preventive
Oncology
- Meetings
- Network and earn CME credits at our
international symposia.
|
